The RUNX1‐ETO fusion protein that results from the t(8;21) chromosomal translocation found in 5–10% of AML patients antagonizes the activity of wild‐type RUNX1 encoded by the remaining unaffected allele. This evidence concerns the gene RUNX1 and acute myeloid leukemia.